Dishman Pharmaceuticals & Chemicals (Delisted) share news and announcements

BSE: 532526

Last traded ₹301.20 on 29 May 2017

Delisted on 8 Jan 2018.

Dishman Pharmaceuticals & Chemicals share news and announcements

747 announcements, routine notices left out, newest first. Page 3 of 15.

Aug 2016
- 31 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2016 to September 27, .... (opens in a new tab)
- 27 Aug · Meeting
  Company has fixed Book Closure from September 20, 2016 to September 27, 2016 for the purpose of the Annual General Meeting of the Company scheduled to be held on September 27, 2016 (opens in a new tab)
- 24 Aug · Management
  Ms. Shrima G. Dave, Asst. company Secretary and compliance officer of the company, is appointed as a "Company Secretary and Compliance officer" of the Company w.e.f August 24, 2016. (opens in a new tab)
- 24 Aug · Management
  Ms. Shrima G. Dave, Asst. Company Secretary and Compliance Officer of the Company, is appointed as a “Company Secretary and .... (opens in a new tab)
- 6 Aug · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Details of voting results of the Court Convened Meeting of the Company held on the August 5, 2016 along with Report of Scrutinizer. (opens in a new tab)
- 6 Aug · Results
  Details of Voting results at the Court Convened Meeting held on August 05, 2016, under Regulation 44(3) of SEBI .... (opens in a new tab)
- 4 Aug · Analysts
  Re-Schedulement of the Conference Call. (opens in a new tab)
- 4 Aug
  Re-Schedulement of time of Conference Call (opens in a new tab)
- 3 Aug · Intimation of Conference Call
  Company has arranged Conference Call with Investors on August 04, 2016 at 4.00 P.M. IST to discuss the financial result .... (opens in a new tab)
- 3 Aug · Analysts
  Intimation of Conference Call. (opens in a new tab)
- 3 Aug · Limited Review Report
  Limited Review Report. (opens in a new tab)
- 3 Aug · Limited Review Report for June 30, 2016
  1. Standalone Limited Review for the period ended June 30, 2016 (opens in a new tab)
- 3 Aug · Results
  Standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016. (opens in a new tab)
- 3 Aug · Results
  1. Standalone Financial Results for the period ended June 30, 2016 2. Consolidated Financial Results for .... (opens in a new tab)
Jul 2016
- 25 Jul · Board meeting
  Meeting of the Board of Directors of the Company will be held on Wednesday, the August 03, 2016 at 11:00 a.m. at Ahmedabad, ....
- 25 Jul · Board meeting
  Inter alia, to take note of the Un-Audited Financial Results of the Company for the quarter ended on June 30, 2016. (opens in a new tab)
- 25 Jul · Confirmation under Reg. 57(2) of SEBI (LODR) Regulations, 2015
  Confirmation under Regulation 57(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 19 Jul · Shareholding for the Period Ended June 30, 2016
  Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
- 16 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under .... (opens in a new tab)
- 14 Jul · Updates
  Company's wholly owned subsidiary, namely Carbogen Amcis AG., Switzerland, had successfully completed US FDA lnspection for its two sites located at Aarau and Neuland without any adverse observations and received the Establishment lnspection Report (ElR) for the same. Thus, now the company has the above two sites in addition to Bubendorf in Switzerland, which are approved by the USFDA. Additlonally, the company's site at Naroda had also successfully completed USFDA lnspection and received the Establishment lnspection Report (ElR) for the same. (opens in a new tab)
- 14 Jul · Company’s site at Naroda and its subsidiary, Carbogen Amcis AG's sites at Aarau and Neuland in Switzerland successfully Pass USFDA Inspection
  Company's wholly owned subsidiary, namely Carbogen Amcis AG., Switzerland, had successfully completed US FDA Inspection .... (opens in a new tab)
- 12 Jul · Court Convened Meeting Updates
  News Paper Cuttings of Notice Of Court Convened Meeting of Equity Shareholders and Creditors (Secured And Un-Secured) for Scheme of Arrangement and Amalgamation (opens in a new tab)
- 11 Jul · Updates
  Renewal of US FDA inspection of Company's Bavla facility has been successfully completed on July 08, 2016. (opens in a new tab)
- 9 Jul · Updates
  Renewal of US FDA inspection of Company’s Bavla facility has been successfully completed on July 08, 2016.
- 9 Jul · Court Convened Meeting on August 05, 2016
  Court Convened Meeting of Equity Shareholders and Creditors (Secured & Unsecured) of the Company will be held on August 05, 2016. (opens in a new tab)
- 9 Jul · Court Convened Meeting Updates
  Notice of court Convened Meeting of equity shareholders, secured Creditors and Un-Secured Creditors of the Company (opens in a new tab)
Jun 2016
- 7 Jun · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
May 2016
- 30 May · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 26 May · Legal
  Exchange had sought clarification from the Company with respect to announcement dated May 19, 2016, regarding Outcome of Board Meeting held on May 19, 2016.The reply of the Company is attached. (opens in a new tab)
- 25 May · Updates
  Transcript of Conference Call (opens in a new tab)
- 21 May · Change in Company Secretary/Compliance Officer
  Ms. Shrima G. Dave, Asst. Company Secretary of the Company is designated as Compliance Officer of the Company w.e.f. May 21, 2016 in place of Ms. Pinaz H. Pithadia. (opens in a new tab)
- 21 May · Change in Compliance Officer
  Ms. Shrima G Dave, Asst. Company Secretary of the Company is designated as Compliance Officer of the Company w.e.f. May 21, ....
- 20 May · Legal
  Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to announcement dated 19-May-2016, regarding " Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2016."On basis of above the Company is required to clarify following:1. The amount and percentage of the turnover or revenue or income and net worth contributed by such subsidiary of the listed entity during the last financial year;2. Date on which the agreement for sale has been entered into;3. The expected date of completion of sale/disposal;4. Consideration received from such sale/disposal;5. Brief details of buyers and whether any of the buyers belong to the promoter/ promoter group/group companies. If yes, details thereof.6. Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length";7. Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.The response of the Company is awaited.
- 20 May · Result Presentation for March 31, 2016
  1. Result Presentation for the period ended March 31, 2016 (opens in a new tab)
- 20 May · Updates
  Investor Presentation on financial result for the quarter and year ended March 31, 2016 made to Analyst and Investors. (opens in a new tab)
- 19 May · Management
  1. Standalone Auditors Report for the period ended March 31, 2016 2. Consolidated Auditors Report for the .... (opens in a new tab)
- 19 May · Updates
  Intimation of Conference Call. (opens in a new tab)
- 19 May · Information as per Regulation 52
  Information regarding Regulation 52 of SEBI (LODR) Regulations, 2015. (opens in a new tab)
- 19 May · Updates
  Company has arranged Conference Call with investors on May 20, 2016. (opens in a new tab)
- 19 May
  Intimation of Conference Call (opens in a new tab)
- 19 May · Board meeting
  Board of Directors of the Company at its meeting held on May 19, 2016, inter alia, to consider and take on record the .... (opens in a new tab)
- 19 May · Board meeting
  Outcome of Board Meeting held on May 19, 2016. (opens in a new tab)
- 19 May · Updates
  Form A for the Financial Year 2015-2016 as per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 19 May · Form A for March 31, 2016
  1. Standalone Form A for the period ended March 31, 2016 (opens in a new tab)
- 19 May · Results
  Standalone & consolidated financial results for the period ended March 31, 2016. (opens in a new tab)
- 19 May · Results
  1. Standalone Financial Results for the period ended March 31, 2016 2. Consolidated Financial Results for .... (opens in a new tab)
- 13 May · Meeting
  Minutes of proceedings of Declaration of Result of Postal Ballot held on April 21, 2016. (opens in a new tab)
- 13 May · Meeting
  Minutes of Proceedings of Declaration of Result of Postal Ballot held on April 21, 2016. (opens in a new tab)
- 7 May · Disclosure
  Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 5 May · Corporate action
  Management Committee of Board of Directors of the Company vide resolution passed in their meeting held on May 05, 2016 ....